Health equity
FDA Approval for Obesity Pill Orforglipron?
Eli Lilly’s development of Orforglipron, a weight-loss drug, has become a significant topic in public health. This oral medication, designed as an alternative to injectable weight-loss treatments, has shown promising results in clinical trials and is set to seek FDA approval shortly. Orforglipron: A Breakthrough in Obesity Treatment This experimental drug falls under the category […]
Read more →